Drug Trial Radar · NCT02396459
Triac Trial II in MCT8 Deficiency Patients
Last checked: Nov 19, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
22
Actual
Start
Dec 7, 2020
Primary completion
Jul 18, 2027
Study completion Aug 18, 2027
Sponsor
- Lead sponsor
- Rare Thyroid Therapeutics International ABIndustry
- Sponsor type
- Industry
- Collaborators
- Erasmus Medical Center
- First posted
- Mar 24, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, up to 30 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will investigate the effect of treatment with tiratricol (also called Triac) in young boys (≤30 months) with MCT8 deficiency (also called the Allan-Herndon-Dudley syndrome (AHDS)). The hypothesis tested is that treatment with tiratricol will have a beneficial effect on the hypothyroid state in the brain as well as the hyperthyroid state in peripheral organs and tissues in these patients. Patients will initially be treated for 96 weeks with tiratricol, treatment effect on neurodevelopment impairment caused by hypothyroidism and peripheral thyrotoxicosis will be evaluated after 96 weeks treatment. Patients will be offered to continue on treatment for an additional 3 years.
Conditions
- Allan-Herndon-Dudley Syndrome
Interventions
TiratricolDrug
Tiratricol, individually titrated dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Gross Motor Function Measure 88 (GMFM 88) total scoreTime frame: 96 weeks, Year 3, Year 4 and Year 5
- Bayley Scales of Infant Development III Gross Motor Skill Domain scoreTime frame: 96 weeks, Year 3, Year 4 and Year 5
Locations
5 sites in 4 countries. Site status is shown where the registry gives one.
Oregon Health & Science University (OHSU) Doernbecher Childrens Hospital
Portland, Oregon
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Charles University and Motol University Hospital; The department of peadiatrics of the 2nd faculty of medicine
Prague, Czechia
Charité - Universitätsmedizin Berlin Institut fur experimental paediatrische endokrinologie
Berlin, Germany
Erasmus MC
Rotterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.